Hussein A Assi et al

Article Type

Changed

Fri, 01/04/2019 - 11:11

Display Headline

Neuroendocrine carcinoma of the larynx with metastasis to the eyelid

Author(s)

Neuroendocrine tumors are a rare type of neoplasms that comprise only 0.5% of all malignancies.¹ They usually arise from the gastrointestinal tract and the lung.^1,2 Neuroendocrine carcinoma of the head and neck is a relatively rare malignancy described in the literature. The larynx is the most commonly affected region of the head and neck.^3,4 Nevertheless, small-cell carcinoma comprises only 0.5% of all laryngeal cancers.⁵ Neuroendocrine carcinoma of the larynx carries variable prognosis depending on the histological subtype.⁶ Typical carcinoid rarely metastasizes, but atypical carcinoid and small-cell carcinoma have high rates of metastasis, usually in the lung and liver.² Cutaneous metastasis from neuroendocrine carcinoma is an extremely rare entity, with only few cases reported in the English literature.^7,8 We report the case of an elderly man with recurrent laryngeal neuroendocrine carcinoma with metastasis to the eyelid.

Click on the PDF icon at the top of this introduction to read the full article.

Article PDF

JCSO_oct_378_Assi.pdf

Issue

The Journal of Community and Supportive Oncology - 13(10)

Publications

The Journal of Community and Supportive Oncology

MDedge Hematology and Oncology

Topics

Head & Neck/Thyroid Cancers

Page Number

378-380

Legacy Keywords

laryngeal neuroendocrine carcinoma, neuroendocrine carcinoma, neoplasm, head and neck, small-cell carcinoma, cutaneous metastasis

Read more about Neuroendocrine carcinoma of the larynx with metastasis to the eyelid

Sections

Case Reports

Author(s)

Hussein A Assi et al

Author(s)

Hussein A Assi et al

Article PDF

JCSO_oct_378_Assi.pdf

Article PDF

JCSO_oct_378_Assi.pdf

Neuroendocrine tumors are a rare type of neoplasms that comprise only 0.5% of all malignancies.¹ They usually arise from the gastrointestinal tract and the lung.^1,2 Neuroendocrine carcinoma of the head and neck is a relatively rare malignancy described in the literature. The larynx is the most commonly affected region of the head and neck.^3,4 Nevertheless, small-cell carcinoma comprises only 0.5% of all laryngeal cancers.⁵ Neuroendocrine carcinoma of the larynx carries variable prognosis depending on the histological subtype.⁶ Typical carcinoid rarely metastasizes, but atypical carcinoid and small-cell carcinoma have high rates of metastasis, usually in the lung and liver.² Cutaneous metastasis from neuroendocrine carcinoma is an extremely rare entity, with only few cases reported in the English literature.^7,8 We report the case of an elderly man with recurrent laryngeal neuroendocrine carcinoma with metastasis to the eyelid.

Click on the PDF icon at the top of this introduction to read the full article.

Neuroendocrine tumors are a rare type of neoplasms that comprise only 0.5% of all malignancies.¹ They usually arise from the gastrointestinal tract and the lung.^1,2 Neuroendocrine carcinoma of the head and neck is a relatively rare malignancy described in the literature. The larynx is the most commonly affected region of the head and neck.^3,4 Nevertheless, small-cell carcinoma comprises only 0.5% of all laryngeal cancers.⁵ Neuroendocrine carcinoma of the larynx carries variable prognosis depending on the histological subtype.⁶ Typical carcinoid rarely metastasizes, but atypical carcinoid and small-cell carcinoma have high rates of metastasis, usually in the lung and liver.² Cutaneous metastasis from neuroendocrine carcinoma is an extremely rare entity, with only few cases reported in the English literature.^7,8 We report the case of an elderly man with recurrent laryngeal neuroendocrine carcinoma with metastasis to the eyelid.

Click on the PDF icon at the top of this introduction to read the full article.

Issue

The Journal of Community and Supportive Oncology - 13(10)

Issue

The Journal of Community and Supportive Oncology - 13(10)

Page Number

378-380

Page Number

378-380

Publications

The Journal of Community and Supportive Oncology

MDedge Hematology and Oncology